Richard M Day
Overview
Explore the profile of Richard M Day including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hendow E, Iacoviello F, Casajuana Ester M, Pellet-Many C, Day R
Adv Healthc Mater
. 2024 Sep;
13(31):e2401832.
PMID: 39258380
Promoting neovascularization is a prerequisite for many tissue engineering applications and the treatment of cardiovascular disease. Delivery of a pro-angiogenic stimulus via acellular materials offers several benefits over biological therapies...
2.
Bettini A, Camelliti P, Stuckey D, Day R
Adv Sci (Weinh)
. 2024 Jun;
11(32):e2404355.
PMID: 38900068
Cell therapy is a potential novel treatment for cardiac regeneration and numerous studies have attempted to transplant cells to regenerate the myocardium lost during myocardial infarction. To date, only minimal...
3.
Ho H, Day R, Craig D
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794324
Chitosan-triphosphate (TPP) nanogels are widely studied drug delivery carrier systems, typically prepared via a simple mixing process. However, the effects of the processing factors on nanogel production have not been...
4.
Bettini A, Patrick P, Day R, Stuckey D
Adv Healthc Mater
. 2024 Apr;
13(17):e2303588.
PMID: 38678393
Targeted delivery and retention are essential requirements for implantable tissue-engineered products. Non-invasive imaging methods that can confirm location, retention, and biodistribution of transplanted cells attached to implanted tissue engineering scaffolds...
5.
Keskin-Erdogan Z, Mandakhbayar N, Jin G, Li Y, Chau D, Day R, et al.
J Biomed Mater Res A
. 2024 Feb;
112(7):1070-1082.
PMID: 38400701
Combinations of different biomaterials with their own advantages as well as functionalization with other components have long been implemented in tissue engineering to improve the performance of the overall material....
6.
Developing a Cell-Microcarrier Tissue-Engineered Product for Muscle Repair Using a Bioreactor System
Cartaxo A, Fernandes-Platzgummer A, Rodrigues C, Melo A, Tecklenburg K, Margreiter E, et al.
Tissue Eng Part C Methods
. 2023 Oct;
29(12):583-595.
PMID: 37842845
Fecal incontinence, although not life-threatening, has a high impact on the economy and patient quality of life. So far, available treatments are based on both surgical and nonsurgical approaches. These...
7.
McCord B, Day R
Sci Rep
. 2023 Sep;
13(1):15935.
PMID: 37741931
Sporadic inclusion body myositis (sIBM) is an idiopathic inflammatory myopathy with invasion of CD8 T cells in muscle and aggregation of proteins in the sarcoplasm. TDP-43 and p62 are two...
8.
McCord B, Day R
Mediators Inflamm
. 2023 Sep;
2023:9018470.
PMID: 37731843
Skeletal muscle of patients with sporadic inclusion body myositis (sIBM) presents with inflammation, including upregulation of inflammatory cytokines such as interferon (IFN). Non-inflammatory features are also observed, like the sarcoplasmic...
9.
Desprez C, Danovi D, Knowles C, Day R
J Tissue Eng
. 2023 Mar;
14:20417314221139794.
PMID: 36949843
Skeletal muscle-derived cells (SMDC) hold tremendous potential for replenishing dysfunctional muscle lost due to disease or trauma. Current therapeutic usage of SMDC relies on harvesting autologous cells from muscle biopsies...
10.
Casajuana Ester M, Day R
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839984
In recent years, extracellular vesicles (EVs) have emerged as promising biomarkers, cell-free therapeutic agents, and drug delivery carriers. Despite their great clinical potential, poor yield and unscalable production of EVs...